Alternate Text DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.

CBL0137

  Cat. No.:  DC10617   Featured
Chemical Structure
1197996-80-7
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
CBL0137 is a metabolically stable curaxin that activates p53 with an EC50 value of 0.37 µM and inhibits NF-κB with an EC50 of 0.47 µM.
Cas No.: 1197996-80-7
Chemical Name: CBL 0137
Synonyms: 1,1'-(9-(2-(Isopropylamino)ethyl)-9H-carbazole-3,6-diyl)diethanone;1-[6-acetyl-9-[2-(propan-2-ylamino)ethyl]carbazol-3-yl]ethanone;AK126635;CBL-0137 free base;KB-216069;SureCN2361265;UNII-8XKR07H9ER;8XKR07H9ER;EX-A4237;CHEMBL4640631;Ethanone, 1,1'-[9-[2-[(1-methylethyl)amino]ethyl]-9H-carbazole-3,6-diyl]bis-;1,1'-{9-[2-(Isopropylamino)ethyl]-9H-carbazole-3,6-diyl}diethanone;JKCSODVERGVDLT-UHFFFAOYSA-N;BCP29977;cbl0137;NSC-789040;CS-0014629;Curaxin-137;CBL-0137;Curaxin 137;1-[6-acetyl-9-[2-(isopropylamino)ethyl]carbazol-3-yl]ethanone;1,1'-{9-[2-(propan-2-ylamino)ethyl]-9H-carbazole-3,6-diyl}diethanone;TS-08988;HY-18935;1,1'-(9-(2-(isopropylamino)ethyl)-9H-carbazole-3,6-diyl)bis(ethan-1-one);BC165662;F78005;NSC789040;BDBM50544058;CHEBI:138650;3,6-diacetyl-9-(2-isopropylethyl)-9H-carbazole;CBL 0137;SB17204;CBL 137; Curaxin 137;SCHEMBL2361265;DTXSID10152589;CBL-0137; CBL 0137; Curaxin 137;AKOS016012947;Q27271162;1197996-80-7
SMILES: CC(C)NCCN1C2=C(C=C(C=C2)C(=O)C)C3=C1C=CC(=C3)C(=O)C
Formula: C21H24N2O2
M.Wt: 336.42746
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: CBL0137 is a metabolically stable curaxin that activates p53 with an EC50 value of 0.37 µM and inhibits NF-κB with an EC50 of 0.47 µM. CBL0137 has broad anticancer activity in mice when administered orally, eradicates drug-resistant cancer stem cells, and potentiates efficacy of gemcitabine (Item No. 11690) in preclinical models of pancreatic cancer.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC10617 CBL0137 CBL0137 is a metabolically stable curaxin that activates p53 with an EC50 value of 0.37 µM and inhibits NF-κB with an EC50 of 0.47 µM.
X